The approval builds on the launch of the assay as a Research Use Only product in May 2026
The server lets scientists connect their own AI assistants directly to their laboratory data
Qureight’s Fibr8 is being used a secondary endpoint in Contineum’s PROPEL-IPF Phase 2 clinical trial examining the safety and efficacy of PIPE-791
New platform connects function and morphology for deeper insights at unprecedented resolution
CryptiVax-1001 targets advanced high-grade serous ovarian cancer
Sign in to your account